109 related articles for article (PubMed ID: 7921780)
1. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.
Meade CJ; Birke F; Metcalfe S; Watson C; Jamieson N; Neild G
J Lipid Mediat Cell Signal; 1994 May; 9(3):205-15. PubMed ID: 7921780
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis.
Iatrou C; Moustakas G; Antonopoulou S; Demopoulos CA; Ziroyiannis P
Nephron; 1996; 72(4):611-6. PubMed ID: 8730430
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
4. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
[TBL] [Abstract][Full Text] [Related]
5. The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats.
Howard KM; Olson MS
J Biol Chem; 2000 Jun; 275(26):19891-6. PubMed ID: 10748027
[TBL] [Abstract][Full Text] [Related]
6. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
[TBL] [Abstract][Full Text] [Related]
7. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
8. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
9. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
Duffy-Krywicki RH; Steinhelper ME; Olson MS
J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells.
Yoshida H; Satoh K; Koyama M; Hiramoto M; Takamatsu S
Am J Hematol; 1996 Nov; 53(3):158-64. PubMed ID: 8895685
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
12. Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase.
Aarsman AJ; Neys FW; Van den Bosch H
Eur J Biochem; 1991 Aug; 200(1):187-93. PubMed ID: 1879423
[TBL] [Abstract][Full Text] [Related]
13. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
14. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
Miwa M; Miyake T; Yamanaka T; Sugatani J; Suzuki Y; Sakata S; Araki Y; Matsumoto M
J Clin Invest; 1988 Dec; 82(6):1983-91. PubMed ID: 3198761
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome.
Trimoreau F; François B; Desachy A; Besse A; Vignon P; Denizot Y
Mediators Inflamm; 2000; 9(3-4):197-200. PubMed ID: 11132779
[TBL] [Abstract][Full Text] [Related]
16. The platelet-activating factor acetylhydrolase of mouse platelets.
Karpouza AP; Vakirtzi-Lemonias C
Biochim Biophys Acta; 1997 Jan; 1323(1):12-22. PubMed ID: 9030208
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor acetylhydrolase in human seminal plasma.
Letendre ED; Miron P; Roberts KD; Langlais J
Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
[TBL] [Abstract][Full Text] [Related]
18. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M
Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
Vadas P; Gold M; Perelman B; Liss GM; Lack G; Blyth T; Simons FE; Simons KJ; Cass D; Yeung J
N Engl J Med; 2008 Jan; 358(1):28-35. PubMed ID: 18172172
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
